Oct 20 (Reuters) - Kenvue (KVUE.N), opens new tab has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during ...
Kenvue urged the Food and Drug Administration to deny a proposal to add further warnings to acetaminophen products after the Trump Administration linked Tylenol use during pregnancy to autism. The ...
Kenvue is the world’s largest pure-play consumer health company by revenue, generating over $15 billion in annual sales. The former consumer segment of Johnson & Johnson spun off and went public in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback